Soleno Therapeutics, Inc.

Drive the commercialization of DCCR for Prader-Willi syndrome by engaging medical specialists and building relationships with caregivers and families. Develop and execute territory strategies to raise brand awareness and ensure patient enrollment in treatment programs.

Drive the commercial launch and sales of Vykat XR for Prader-Willi syndrome by engaging healthcare professionals and caregivers. Develop and execute territory strategies to raise brand awareness and ensure patient enrollment in treatment programs.

Drive the commercial launch and sales of DCCR for Prader-Willi syndrome by engaging healthcare professionals and caregivers. Develop and execute territory strategies to raise brand awareness and ensure patient enrollment in treatment programs.